Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $6.1000 (-0.65%) ($6.0350 - $6.1000) on Sun. Apr. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 45 | Latest Price | $6.1000(-0.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 2% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -2.095% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.39 | 5 Day Moving Average | $6.27(-2.71%) | 10 Day Moving Average | $6.12(-0.33%) | 20 Day Moving Average | $6.39(-4.54%) | To recent high | -26% | To recent low | 10.5% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |